Inside the research
Veeva Systems Inc.
VEEV Research profile · latest available data
Price overview
$280.68
▲ +5.84 (+2.1%)
| 52w hi | $306.22 |
|---|---|
| 52w lo | $151.43 |
| Vol | 1.74M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.42
| Short | +0.30 |
|---|---|
| Medium | +0.53 |
| Long | +0.41 |
computed 2026-09-27
Key fundamentals
Veeva Systems Inc.
Healthcare · Health Information Services
| Market cap | $45.44B |
|---|---|
| Enterprise value | $38.35B |
| Trailing P/E | 46.09x |
| Forward P/E | 27.38x |
| EV / EBITDA | 35.67x |
| P / S (ttm) | 13.14x |
| Profit margin | 29.3% |
| Return on equity | 14.4% |
| Revenue growth | +17.6% |
| Earnings growth | +39.5% |
| Debt / equity | 2.04 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.26 | |
| Sector | +0.08 | |
| Technical | +0.25 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Risk Metrics
| Beta vs SPX | 0.67 |
|---|---|
| Corr SPX | 0.28 |
| Annual vol | 39.3% |
| Annual ret | +20.9% |
| Sharpe | 0.53 |
| Max DD | -50.5% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $264.46 |
|---|---|
| High / Low | $350.00 / $176.00 |
| Median | $272.50 |
| Analysts | 28 |
| Strong Buy | 8 | |
|---|---|---|
| Buy | 14 | |
| Hold | 7 | |
| Sell | 1 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-04-10 | Citigroup | → Neutral |
| 2026-03-09 | Citigroup | → Buy |
| 2026-03-05 | Wells Fargo | → Overweight |
| 2026-03-05 | UBS | → Neutral |
| 2026-03-05 | Truist Securities | → Buy |
| 2026-03-05 | TD Cowen | → Buy |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-06-18 | Shareholder Vote, Exhibits | read |
| 2026-06-03 | Earnings Release, Exhibits | read |
| 2026-04-20 | Officer / Director Change, Exhibits | read |
| 2026-03-04 | Earnings Release, Exhibits | read |
| 2026-01-05 | Other Material Event, Exhibits | read |
| 2025-12-11 | Officer / Director Change, Exhibits | read |
| 2025-11-20 | Earnings Release, Exhibits | read |
| 2025-11-18 | Officer / Director Change, Exhibits | read |
| 2025-08-27 | Earnings Release, Exhibits | read |
| 2025-08-18 | Reg FD Disclosure, Exhibits | read |
| 2025-06-23 | Shareholder Vote, Exhibits | read |
| 2025-05-28 | Earnings Release, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 1 |
| Top-5 share | 100.0% |
| HHI | 10,000 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Ark Invest | $9.20M | 41.22K |
As of 2025-12-31
SEC Filings
The Long Run
FY 2013–2026 · 12 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.36B | +49.0% | |
| Gross profit | $1.69B | +33.1% | |
| Operating income | $916.37M | +51.0% | |
| Net income | $908.91M | +57.8% | |
| Cash from ops | $1.42B | +125.8% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $276.84 | $282.81 | $275.91 | $280.68 | 1.74M |
| Sep 24 | $270.91 | $276.24 | $270.68 | $274.84 | 1.38M |
| Sep 23 | $263.25 | $272.18 | $263.00 | $270.75 | 1.43M |
| Sep 22 | $265.80 | $265.80 | $259.34 | $260.91 | 1.82M |
| Sep 21 | $260.00 | $264.42 | $257.87 | $261.31 | 1.20M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →